CRBP β€” CORBUS PHARMACEUTICALS HLDGS

Ownership history in Advisory Services Network, LLC  Β·  3 quarters on record

This page tracks every 13F SEC filing in which Advisory Services Network, LLC reported a position in CORBUS PHARMACEUTICALS HLDGS (CRBP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

Position Intelligence

Advisory Services Network, LLC Γ— CRBP AI Analytics

πŸ“‰ Advisory Services Network, LLC underperformed the S&P 500 by –398.5% annually on this CRBP position. Average cost basis: $39.86. Maximum drawdown during holding period: –76.6%.

πŸ“ˆ Position Alpha vs SPY
-398.5%
annualised excess return

❌ Significantly underperformed the S&P 500 by 398.5% ann.
2 quarters analyzed

πŸ’° Entry Quality
$39.86
-68.3% vs current ($12.65)

Best entry: $37.50 (2020 Q4)  Β·  Worst: $54.00 (2020 Q3)

πŸ›‘οΈ Drawdown Resilience
–76.6%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
67%
buy-side decisions

2 adds Β· 1 trim. Bought during 1 of 2 down-price quarters. πŸ“ˆ More buys than sells across the holding period.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.0% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    CRBP price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 3 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 14 -6,986 -99.8% 0.00% $177 $12.65
2020 Q4 ADDED 7,000 +6,000 +600.0% 0.00% $9K $37.50
2020 Q3 INITIATED 1,000 β€” β€” 0.00% $2K $54.00
← Back to Advisory Services Network, LLC Holdings